28 December 2021 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in realtime iCMR cardiac ablation products, is pleased to announce that the German Heart Centre Berlin (https://www.dhzb.de/en/), and the Charité Medical University, Virchow-Klinikum Campus (Charité) (https://www.charite.de/en/), both in Berlin, Germany, are the latest two institutions to adopt Imricor’s iCMR ablation solutions.
The Company signed an Equipment Purchase Agreement (Agreement) with the German Heart Centre Berlin to outfit an existing CMR facility for iCMR procedures. Both institutions will then utilize the iCMR lab at the Heart Centre.
Imricor’s Chair and CEO, Steve Wedan, said: “The addition of these two world-renowned institutions is a major step forward for Imricor, and we are thrilled to add them to our customer base by year-end 2021, as we planned.
“These sites have well-established facilities and programs like the MRI Core Lab (https://tinyurl.com/2p8nvtv2) and the CMR-Academy (https://tinyurl.com/vfnem8tw), and we look forward to growing and deepening our relationships and collaborations with them in the coming months and years.”
The Agreement marks a significant milestone to bring realtime iCMR cardiac ablation procedures across Europe. Planning is underway for procedures to commence in the first half of 2022 for both institutions.